Position in NBIX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$229,720
-$148,242 QoQ
Shares Held
1,363
-52.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#583
of 772 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026waypoint wealth counsel holds $229,720 across 1 Drug Manufacturers - Specialty & Generic name. NBIX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,363 | $229,720 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $229,720 | 1,363 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $377,962 | 2,869 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $468,039 | 3,300 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $426,895 | 3,041 | Shares | Sole | 2025-10-20 | |
| No filing history on record for this holder in this stock. | ||||||